- Investing Ideas
- /
- Swedish Pharmaceuticals & Biotech Financially Fit Penny Stocks
Swedish Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
5
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
5 companies
Novakand Pharma
Market Cap: SEK 30.6m
Develops drugs for inflammatory diseases and cancer in Sweden and internationally.
NOVKAN
SEK 0.25
7D
-15.8%
1Y
-87.2%
IDL Diagnostics
Market Cap: SEK 92.6m
A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.
IDLDX
SEK 0.40
7D
-2.7%
1Y
-20.4%
Level Bio
Market Cap: SEK 27.1m
Manufactures and distributes cutting-edge solutions in the Nordic region and internationally.
LEVBIO
SEK 0.40
7D
20.0%
1Y
-5.5%
LIDDS
Market Cap: SEK 8.5m
A drug delivery company, develops pharmaceutical products based on its NanoZolid proprietary technology for the treatment of cancer and other diseases in Sweden.
LIDDS
SEK 0.062
7D
13.1%
1Y
-52.3%
Hamlet BioPharma
Market Cap: SEK 746.3m
Engages in the development of drugs for the treatment and prevention of cancer in Sweden.
HAMLET B
SEK 4.20
7D
14.3%
1Y
1.4%